ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARIA ARAULLO-NAGANO MD

3409 LUDINGTON ST SUITE 104

Escanaba | Michigan | 49829

(906) 786-5707

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,149Medicare Part D Prescriptions Filled, Including Refills

Rank: 196 out of 2604

$580K Total Retail Price of All Prescriptions

Rank: 131 out of 2604

328 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 328 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 328 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,315 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 417 319 1 4
LISINOPRIL 344 220 2 3
HYDROCODONE-ACETAMINOPHEN 341 204 S3 3 1
OMEPRAZOLE 330 193 4 5
METFORMIN HCL 230 153 5 7
METOPROLOL TARTRATE 217 147 6 9
LOVASTATIN 194 128 7 24
FUROSEMIDE 173 131 8 8
SIMVASTATIN 161 107 9 2
WARFARIN SODIUM 152 133 10 13
AMLODIPINE BESYLATE 151 128 11 6
GABAPENTIN 150 49 12 12
ATENOLOL 120 108 13 11
ALENDRONATE SODIUM 113 84 14 29
HYDROCHLOROTHIAZIDE 110 91 15 10
ZOLPIDEM TARTRATE 109 70 16 21
ADVAIR DISKUS 105 76 17 41
FLUOXETINE HCL 102 67 18 49
PROAIR HFA 90 45 19 27
CITALOPRAM HBR 89 64 20 18
GEMFIBROZIL 86 40 21 87
PREDNISONE 86 41 21 34
SPIRONOLACTONE 86 57 21 78
TRIAMTERENE-HCTZ 85 75 24 55
TRAMADOL HCL 82 64 25 15
GLYBURIDE 82 56 R 25 83
FENOFIBRATE 79 39 27 69
FENTANYL 78 67 S2 28 48
METOPROLOL SUCCINATE 71 58 29 17
PRAVASTATIN SODIUM 70 46 30 14
VENTOLIN HFA 69 47 31 63
GLIPIZIDE 68 48 32 51
TRAZODONE HCL 64 15 33 46
ATORVASTATIN CALCIUM 61 46 34 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 33 35 91
POLYETHYLENE GLYCOL 3350 60 59 35 42
DONEPEZIL HCL 59 55 37 28
SYMBICORT 57 42 38 105
POTASSIUM CHLORIDE 55 31 39 16
CYMBALTA 55 0 39 44
FLUTICASONE PROPIONATE 55 34 39 31
LANTUS 51 38 42 40
JANUVIA 51 29 42 98
LANTUS SOLOSTAR 50 37 44 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.